Asthma Diagnosis
Asthma Diagnosis
Diagnosis in asthma rests on two things that have to agree: a history of symptoms that vary over time, and objective evidence that airflow obstruction is present and reversible. Neither is sufficient alone. A convincing story with no test leaves the alternative explanations open, and an abnormal number in someone with no symptoms is usually measuring something else. This page sets out what each test adds, what it cannot show, and why a normal result between episodes means very little.
Spirometry and the reversibility test — the first step
Spirometry is a forced breathing manoeuvre that measures how much air can be exhaled in the first second and how much in total, reported as two volumes and their ratio. In asthma the pattern is obstruction — a reduced ratio relative to what is expected for that person. What makes the test specific is its second half: the manoeuvre is repeated after a bronchodilator, and the question becomes whether the obstruction reverses.
Reversibility is judged on the improvement in the first-second volume, expressed both as a percentage and as an absolute volume. The combination matters, because a percentage alone can look impressive in someone whose starting volume is small. What is worth asking for is the numbers rather than the word "positive", since documented figures are what allow the result to be read by anyone else later.
Technique decides whether any of it means anything. Relievers are withheld for the period your team specifies, smoking is avoided beforehand, and the effort is repeated several times because the test depends on it. A technically poor effort can look exactly like a mild obstruction, which is one reason a single number in isolation is a weak basis for a decision.
Two cautions. A normal result between episodes is expected in a disease defined by variability, so the timing of the test matters as much as the test itself. And obstruction that does not reverse at all points elsewhere, most often towards COPD, which is a different condition with a different treatment.
Where the test is arranged, and who performs it, come down to the same answer: pulmonary function testing is carried out by our respiratory and critical care medicine department, and the trace is read by the clinician who holds your history. Where the diagnosis is still open after it, the same department performs radial-probe ultrasound bronchoscopy and, where a peripheral lesion needs sampling, CT- or ultrasound-guided lung biopsy — so the remaining questions are usually answered without a second referral.
Variability: the peak flow diary and the challenge test
Asthma is defined by variation, so a measurement that captures variation over time is often more informative than a single reading on a single day. The usual instrument is the peak flow meter: a forced blow into a small device, recorded twice a day for two weeks.
What is being looked for is the range rather than any individual figure — a difference between morning and evening readings, and a spread across days, larger than the disease should produce. The diary also generates a personal best, and it is that figure which lets a later reading be judged as a fraction of normal — which is what lets an action plan state a threshold rather than an impression.
Doing it in a way that produces usable data is simple and unglamorous: the same meter each time, three blows with the best recorded, measurements before the reliever in the morning and at consistent times, and every number written down — including the bad days, which are the informative ones.
Where spirometry is normal and the history is convincing, a bronchial challenge test can be used instead. The airway is exposed to a standardised stimulus and the response is measured; a negative result is useful in the other direction, because it makes currently active asthma unlikely. The test needs a setting prepared to deal with a reaction, which is why it is arranged deliberately rather than added to a routine visit.
FeNO and eosinophils — measuring the inflammation
Fractional exhaled nitric oxide measures a gas produced in the airway when a particular kind of inflammation — eosinophilic inflammation — is present. It is easy to perform, requiring a steady blow into a handheld analyser, and it produces a number about inflammation rather than about obstruction.
It earns its place in three situations: supporting the diagnosis when the history and spirometry disagree; identifying who has eosinophilic inflammation, which matters because the pattern of inflammation, not the severity of symptoms, decides which add-on treatments are worth considering; and tracking the anti-inflammatory effect of treatment over time.
Several things undermine it. Smoking lowers the reading, a recent viral infection raises it, diet and recent steroid use move it, and one measurement tells you far less than a series. It also says nothing about how open the airway is, which is why it complements spirometry rather than replacing it.
The blood eosinophil count and total IgE do a related job from the blood side, describing the inflammatory pattern and the allergic component. None is diagnostic on its own; together they describe what kind of asthma this is, which is the question that must be answered before an add-on is chosen.
Allergy testing — what it shows and what it does not
Allergy testing looks for sensitisation. Skin prick testing places tiny amounts of common allergens on the skin and looks for a reaction; specific IgE testing measures the corresponding antibodies in blood. Both answer the same question — which allergens does this person's immune system recognise — and neither is a diagnosis of asthma.
The distinction that matters is between sensitisation and causation. A positive result means the immune system recognises the allergen; it does not mean that allergen is causing the airway symptoms. Plenty of sensitised people have no symptoms on exposure, and the only way to establish that something is a trigger is to look at the history: symptoms worse in the bedroom, worse in a particular season, or worse with a pet in the room.
Where results genuinely change management, they do so in three ways: they direct avoidance advice at something that matters, they identify who may be suitable for allergen immunotherapy, and they contribute to the pattern used when a biological treatment is considered in severe asthma.
The caution concerns testing with no validated role. Food-specific IgG panels and broad "sensitivity" tests are widely sold and do not diagnose allergy, and acting on them can lead to unnecessary elimination diets — a particular problem in children. If a result cannot change what is done next, it is worth asking what it is for.
Diagnosis in children, and what is different
Diagnosis is harder in children and is made differently. Wheeze is very common in preschool children, most of it is triggered by viral infections, and much of it settles. The question is not whether a child wheezes but what pattern is emerging: how often, whether there is a dry cough or night waking between episodes, whether there is eczema or allergic rhinitis, and whether allergy runs in the family.
Spirometry is usually possible from around five or six years of age with coaching. Below that, the diagnosis is often made clinically and supported by a trial of treatment followed by a planned review of whether it is still needed, rather than by a test. Peak flow diaries become feasible in older children, and FeNO can be measured in younger ones with suitable equipment.
Three things matter in children and are easily lost. Treatment should not be stopped during a good spell without review, because childhood asthma commonly fluctuates. Inhaler technique with a spacer — and a mask in small children — is a large part of whether treatment works at all. And growth should be monitored in children on inhaled steroids, not because the treatment is unsafe but because monitoring is what keeps that statement true.
There is also a specific age of risk. Adolescence is when adherence most often lapses and when the disease is least likely to be mentioned, while the risk of a severe attack does not disappear. The move from children's to adult services is worth planning rather than drifting through.